2015
Selection of the treatment effect for sample size determination in a superiority clinical trial using a hybrid classical and Bayesian procedure
Ciarleglio MM, Arendt CD, Makuch RW, Peduzzi PN. Selection of the treatment effect for sample size determination in a superiority clinical trial using a hybrid classical and Bayesian procedure. Contemporary Clinical Trials 2015, 41: 160-171. PMID: 25583273, DOI: 10.1016/j.cct.2015.01.002.Peer-Reviewed Original Research
1987
Evaluation of circulating malignant cells provides prognostic information in cutaneous T cell lymphoma.
Schechter G, Sausville E, Fischmann A, Soehnlen F, Eddy J, Matthews M, Gazdar A, Guccion J, Munson D, Makuch R. Evaluation of circulating malignant cells provides prognostic information in cutaneous T cell lymphoma. Blood 1987, 69: 841-9. PMID: 3493044, DOI: 10.1182/blood.v69.3.841.bloodjournal693841.Peer-Reviewed Original ResearchConceptsCutaneous T-cell lymphomaT-cell lymphomaBlood involvementLymphocyte morphologyRisk factorsCell lymphomaCTCL cellsIndependent risk factorExtent of diseasePretreatment risk factorsPeripheral blood lymphocyte morphologyUntreated patientsVisceral diseaseWorse survivalLymph nodesInitial diagnosisT stageAggressive featuresSkin stageCutaneous tumorsSkin plaquesPrognostic informationPatientsMalignant cellsMultivariate analysis
1984
A non‐parametric graphical representation of the relationship between survival and the occurrence of an event: Application to responder versus non‐responder bias
Simon R, Makuch R. A non‐parametric graphical representation of the relationship between survival and the occurrence of an event: Application to responder versus non‐responder bias. Statistics In Medicine 1984, 3: 35-44. PMID: 6729287, DOI: 10.1002/sim.4780030106.Peer-Reviewed Original Research
1982
Sample size requirements for comparing time-to-failure among k treatment groups
Makuch R, Simon R. Sample size requirements for comparing time-to-failure among k treatment groups. Journal Of Clinical Epidemiology 1982, 35: 861-867. PMID: 7142364, DOI: 10.1016/0021-9681(82)90051-0.Peer-Reviewed Original ResearchAdjusted survival curve estimation using covariates
Makuch R. Adjusted survival curve estimation using covariates. Journal Of Clinical Epidemiology 1982, 35: 437-443. PMID: 7042727, DOI: 10.1016/0021-9681(82)90058-3.Peer-Reviewed Original Research
1979
Recommendations for the analysis of the effect of treatment on the development of second malignancies
Makuch R, Simon R. Recommendations for the analysis of the effect of treatment on the development of second malignancies. Cancer 1979, 44: 250-253. PMID: 455251, DOI: 10.1002/1097-0142(197907)44:1<250::aid-cncr2820440141>3.0.co;2-1.Peer-Reviewed Original ResearchMeSH KeywordsAntineoplastic AgentsFollow-Up StudiesHumansNeoplasmsNeoplasms, Multiple PrimaryNeoplasms, Radiation-InducedRiskStatistics as TopicJustification for the lognormal distribution as a model for blood pressure
Makuch R, Freeman D, Johnson M. Justification for the lognormal distribution as a model for blood pressure. Journal Of Clinical Epidemiology 1979, 32: 245-250. PMID: 429469, DOI: 10.1016/0021-9681(79)90070-5.Peer-Reviewed Original Research